AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31928864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar rTMS - daily for 3 days, twice-daily for 5 days
Number of subjects: 72
Study 31928864 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation - twice-daily for 5 days
Number of subjects: 72
Study 31928864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar rTMS
Number of subjects: 72
Study 31881852 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplements
Number of subjects: 299
Study 31881852 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 299
Study 31881852 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet
Number of subjects: 299
Study 28626140 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation (docosahexaenoic acid (DHA) 300 mg/day, eicosapentaenoic acid (EPA) 100 mg/day, arachidonic acid (ARA) 120 mg/day)
Number of subjects: 113
Study 28626140 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 113
Study 28626140 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation
Number of subjects: 113
Study 27150344 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (CAS) for cup placement
Number of subjects: 60
Study 27150344 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique for cup placement (Control)
Number of subjects: 60
Study 25103718 — intervention group
Group type: EXPERIMENTAL
Intervention: Group metacognitive training (MCT) targeting cognitive biases
Number of subjects: 150
Study 25103718 — intervention group
Group type: COMPARATOR
Intervention: Neuropsychological training (COGPACK)
Number of subjects: 150
Study 22038497 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice concentrate
Number of subjects: 20
Study 22038497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18710719 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg
Number of subjects: 30
Study 18710719 — intervention group
Group type: COMPARATOR
Intervention: Placebo (folic acid tablets)
Number of subjects: 30
Study 17140552 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 1200
Study 15985034 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% hydroquinone cream (group A)
Number of subjects: 64
Study 15985034 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone, 0.05% tretinoin and 0.05% dexamethasone cream (group B)
Number of subjects: 64
Study 11928798 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy for rectal cancer
Number of subjects: 0
Study 11928798 — intervention group
Group type: EXPERIMENTAL
Intervention: Less radical surgery
Number of subjects: 0
Study 10096615 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromos 694 Depilation Ruby Laser
Number of subjects: 36
Study 8526599 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (rapid cooling at 4-5 degrees C)
Number of subjects: 39
Study 8526599 — intervention group
Group type: COMPARATOR
Intervention: Group B (slow cooling starting at 18 degrees C)
Number of subjects: 39
Study 2187603 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution A (168 mmol/L sugar, 326 mosm/kg)
Number of subjects: 49
Study 2187603 — intervention group
Group type: COMPARATOR
Intervention: Solution D (90 mmol/L sugar, 240 mosm/kg)
Number of subjects: 49
Study 2187603 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and D)
Number of subjects: 49
Study 6103680 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 to 30 mg per day
Number of subjects: 20
Study 31236874 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 61
Study 31236874 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss (BWL)
Number of subjects: 61
Study 31236874 — intervention group
Group type: COMPARATOR
Intervention: Baseline BMI
Number of subjects: 61
Study 31236874 — intervention group
Group type: COMPARATOR
Intervention: Younger age
Number of subjects: 61
Study 31236874 — intervention group
Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 61
Study 31236874 — intervention group
Group type: COMPARATOR
Intervention: Treatment-related increases in dietary restraint behaviors
Number of subjects: 61
Study 27751654 — intervention group
Group type: EXPERIMENTAL
Intervention: CHR patients
Number of subjects: 144
Study 27751654 — intervention group
Group type: COMPARATOR
Intervention: Control group (GEMCAS)
Number of subjects: 144
Study 26003406 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (aerobics, strength and flexibility training), three sessions a week for 16 weeks.
Number of subjects: 639
Study 26003406 — intervention group
Group type: COMPARATOR
Intervention: Usual daily activities (control group).
Number of subjects: 639
Study 23511304 — intervention group
Group type: EXPERIMENTAL
Intervention: Incompleteness induction
Number of subjects: 0
Study 23511304 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 21135204 — intervention group
Group type: COMPARATOR
Intervention: 10 bp deletion polymorphism in GLUT1 gene
Number of subjects: 96
Study 21135204 — intervention group
Group type: EXPERIMENTAL
Intervention: New variants in GLUT1 gene (c.972+17t>a and c.1016T>C)
Number of subjects: 96
Study 19174530 — intervention group
Group type: EXPERIMENTAL
Intervention: GR genotypes (N363S, BclI, R23K)
Number of subjects: 1000
Study 19174530 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-MS/MS steroid measurements
Number of subjects: 1000
Study 19174530 — intervention group
Group type: EXPERIMENTAL
Intervention: BclI variant
Number of subjects: 1000
Study 17369118 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 43
Study 17369118 — intervention group
Group type: COMPARATOR
Intervention: Control (original regimen)
Number of subjects: 43
Study 15055028 — intervention group
Group type: EXPERIMENTAL
Intervention: Human Fibrin Glue (HFG)
Number of subjects: 50
Study 15055028 — intervention group
Group type: COMPARATOR
Intervention: Control (no Human Fibrin Glue)
Number of subjects: 50
Study 10978856 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-residual enteral formula (Osmolite HN)
Number of subjects: 80
Study 10978856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat enteral formula (Pulmocare)
Number of subjects: 80
Study 10978856 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-containing enteral formula (AlitraQ)
Number of subjects: 80
Study 10978856 — intervention group
Group type: COMPARATOR
Intervention: NPO for 1 week (Control group)
Number of subjects: 80
Study 8775569 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (CIT)
Number of subjects: 8
Study 8775569 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 8
Study 1343610 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal use of episiotomy
Number of subjects: 0
Study 1343610 — intervention group
Group type: COMPARATOR
Intervention: Restricted use of episiotomy
Number of subjects: 0
Study 6148879 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg every 6 hours for 14 days
Number of subjects: 20
Study 6148879 — intervention group
Group type: COMPARATOR
Intervention: Nadolol, 80 mg each morning for 14 days
Number of subjects: 20
Study 6148879 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20
Study 6148879 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 20
Study 6148879 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Nadolol
Number of subjects: 20
Study 3722318 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for acute postpartum mastitis
Number of subjects: 606
Study 3722318 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated women with acute postpartum mastitis
Number of subjects: 606
Study 31609300 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (INT) - alternating 3‐min intervals at 90% and 50% HRpeak
Number of subjects: 18
Study 31609300 — intervention group
Group type: COMPARATOR
Intervention: Continuous training (CONT) - 70% HRpeak
Number of subjects: 18
Study 29389542 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0
Study 27146108 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (Crinone 8% vaginal gel, 90 mg per day) for 14 days in CC/IUI cycles
Number of subjects: 200
Study 27146108 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (Crinone 8% vaginal gel, 90 mg per day) for 14 days in Gn/IUI cycles
Number of subjects: 200
Study 27146108 — intervention group
Group type: COMPARATOR
Intervention: Control group (CC/IUI cycles without luteal-phase support)
Number of subjects: 200
Study 27146108 — intervention group
Group type: COMPARATOR
Intervention: Control group (Gn/IUI cycles without luteal-phase support)
Number of subjects: 200
Study 24244406 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (ICBT) for 10 weeks
Number of subjects: 104
Study 24244406 — intervention group
Group type: COMPARATOR
Intervention: Group cognitive behaviour therapy (GCBT) for 10 weeks
Number of subjects: 104
Study 20507375 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FM-SRP)
Number of subjects: 39
Study 20507375 — intervention group
Group type: COMPARATOR
Intervention: Multiple session scaling and root planing (MS-SRP)
Number of subjects: 39
Study 18405149 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion added to routine treatment, once daily for 10 days.
Number of subjects: 100
Study 18405149 — intervention group
Group type: COMPARATOR
Intervention: Routine therapeutic method without any method for preventing nosocomial infection (Control group).
Number of subjects: 100
Study 16870951 — intervention group
Group type: EXPERIMENTAL
Intervention: α-adrenergic antagonists
Number of subjects: 734
Study 12573204 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85 BV (3.5 mg)
Number of subjects: 40
Study 12573204 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85 BV
Number of subjects: 40
Study 12573204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10894316 — intervention group
Group type: EXPERIMENTAL
Intervention: CIND diagnosis
Number of subjects: 3425
Study 10894316 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, stroke, heart failure
Number of subjects: 3425
Study 10894316 — intervention group
Group type: EXPERIMENTAL
Intervention: Education, smoking
Number of subjects: 3425
Study 10894316 — intervention group
Group type: EXPERIMENTAL
Intervention: CIND
Number of subjects: 3425
Study 8852304 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenspan's original model of personal competence
Number of subjects: 323
Study 8852304 — intervention group
Group type: COMPARATOR
Intervention: AAMR model including adaptive skills
Number of subjects: 323
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 400 micrograms bolus followed by 40 micrograms/h infusion
Number of subjects: 63
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 800 micrograms bolus followed by 40 micrograms/h infusion
Number of subjects: 63
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 800 micrograms bolus after 2-chloroprocaine
Number of subjects: 63
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 400 micrograms bolus after 2-chloroprocaine
Number of subjects: 63
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine (both doses) after bupivacaine
Number of subjects: 63
Study 1736694 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine after bupivacaine
Number of subjects: 63
Study 1736694 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline (control)
Number of subjects: 63
Study 6736662 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine gluconate
Number of subjects: 150
Study 6736662 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone-iodine (1% free iodine)
Number of subjects: 150
Study 31085043 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib and Bevacizumab
Number of subjects: 80
Study 31085043 — intervention group
Group type: COMPARATOR
Intervention: Osimertinib
Number of subjects: 80
Study 31085043 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Osimertinib + Bevacizumab)
Number of subjects: 80
Study 29698651 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (EX, n=216)
Number of subjects: 430
Study 29698651 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (NON-EX, n=214)
Number of subjects: 430
Study 27456718 — intervention group
Group type: EXPERIMENTAL
Intervention: Nooclerin (deanol aceglumate) for 2 months
Number of subjects: 40
Study 27456718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24791605 — intervention group
Group type: EXPERIMENTAL
Intervention: TF‐CBT plus evidence‐based engagement strategies
Number of subjects: 47
Study 24791605 — intervention group
Group type: COMPARATOR
Intervention: TF‐CBT standard delivery
Number of subjects: 47
Study 22372795 — intervention group
Group type: EXPERIMENTAL
Intervention: VECAM 40
Number of subjects: 36
Study 22372795 — intervention group
Group type: EXPERIMENTAL
Intervention: VECAM 20
Number of subjects: 36
Study 22372795 — intervention group
Group type: COMPARATOR
Intervention: OMP 20 mg
Number of subjects: 36
Study 20928987 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprinkles (micronutrient home supplementation with iron, vitamins A and C, folic acid, and zinc)
Number of subjects: 621
Study 20928987 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (liquid iron and vitamins A and D)
Number of subjects: 621
Study 20928987 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprinkles
Number of subjects: 621
Study 20928987 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 621
Study 17993007 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinnaoxin capsules
Number of subjects: 118
Study 17993007 — intervention group
Group type: COMPARATOR
Intervention: Nimodiping
Number of subjects: 118
Study 15644006 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml.h(‐1) ropivacaine 0.2% (study group, n = 21)
Number of subjects: 42
Study 15644006 — intervention group
Group type: COMPARATOR
Intervention: 5 ml.h(‐1) saline (control group, n = 21)
Number of subjects: 42
Study 12134102 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical closure of arteriovenous fistula
Number of subjects: 17
Study 12134102 — intervention group
Group type: COMPARATOR
Intervention: Control group (patent arteriovenous fistulas)
Number of subjects: 17
Study 10900674 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 10900674 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 0
Study 10900674 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogens
Number of subjects: 0
Study 10900674 — intervention group
Group type: COMPARATOR
Intervention: HRT
Number of subjects: 0
Study 8872628 — intervention group
Group type: EXPERIMENTAL
Intervention: 700-ml infusion of autologous erythrocytes (42% hematocrit)
Number of subjects: 16
Study 8872628 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 16
Study 8872628 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte infusion
Number of subjects: 16
Study 1732596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical epirubicin administration
Number of subjects: 65
Study 1732596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epirubicin)
Number of subjects: 65
Study 2857372 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-care service for acute stroke patients
Number of subjects: 440
Study 2857372 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 440
Study 30705097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated-asparaginase, intravenously at a dose of 2,500 IU/m2 on days 12 and 26
Number of subjects: 736
Study 28038881 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract plus diclofenac tablet
Number of subjects: 50
Study 28038881 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac tablet alone
Number of subjects: 50
Study 27573032 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-guided PCI
Number of subjects: 240
Study 27573032 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided PCI (angiography-guided group)
Number of subjects: 240
Study 23584930 — intervention group
Group type: EXPERIMENTAL
Intervention: Building on Family Strengths (BFS) curriculum
Number of subjects: 100
Study 21696247 — intervention group
Group type: EXPERIMENTAL
Intervention: Aided paper and pen visual perception training
Number of subjects: 40
Study 21696247 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based visual perception training
Number of subjects: 40
Study 21696247 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 40
Study 20538368 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Sedation (PCS)
Number of subjects: 166
Study 20538368 — intervention group
Group type: COMPARATOR
Intervention: Emergency Physician-Controlled Sedation (EPCS)
Number of subjects: 166
Study 18164464 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 0
Study 15957997 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 activity in follicular fluid and culture media
Number of subjects: 0
Study 15957997 — intervention group
Group type: COMPARATOR
Intervention: MMP-2 activity in follicular fluid and culture media
Number of subjects: 0
Study 15957997 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 expression in follicular fluid and culture media
Number of subjects: 0
Study 12598214 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home self-adjustment of CPAP (starting pressure based on prediction equation)
Number of subjects: 18
Study 12598214 — intervention group
Group type: COMPARATOR
Intervention: In-laboratory determined optimal pressure CPAP treatment
Number of subjects: 18
Study 10413395 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Practice
Number of subjects: 509
Study 10413395 — intervention group
Group type: COMPARATOR
Intervention: General Internal Medicine
Number of subjects: 509
Study 8585108 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg once daily
Number of subjects: 14
Study 8585108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2149053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus teicoplanin
Number of subjects: 100
Study 2149053 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin
Number of subjects: 100
Study 7452214 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 7452214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31204681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0
Study 31204681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic antibiotics)
Number of subjects: 0
Study 28655025 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM2038 24 mg
Number of subjects: 47
Study 28655025 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM2038 32 mg
Number of subjects: 47
Study 25425205 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based family communication intervention
Number of subjects: 0
Study 25425205 — intervention group
Group type: COMPARATOR
Intervention: Comparison families (control group)
Number of subjects: 0
Study 22776322 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissurectomy with anoplasty
Number of subjects: 264
Study 20535518 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+NDL (SRP followed by Nd:YAG laser)
Number of subjects: 30
Study 20535518 — intervention group
Group type: COMPARATOR
Intervention: SRP (Scaling and Root Planing)
Number of subjects: 30
Study 19785510 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (0.5 to 1.2 mg/kg/day, uptitrated after two weeks)
Number of subjects: 151
Study 19785510 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 151
Study 19785510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 16923216 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly chopped chilli blend (30 g/d; 55% cayenne chilli)
Number of subjects: 27
Study 16923216 — intervention group
Group type: COMPARATOR
Intervention: Bland diet (no chilli)
Number of subjects: 27
Study 14990637 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 135
Study 14990637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 11333377 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventative methods to reduce vertical transmission of HIV
Number of subjects: 0
Study 9394683 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (40% of energy as fat)
Number of subjects: 14
Study 9394683 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (20% of energy as fat)
Number of subjects: 14
Study 9394683 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 14
Study 8030582 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepiphylline (8 mg/kg/day divided in 3 doses for 10 days)
Number of subjects: 40
Study 8030582 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 8030582 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepiphylline (8 mg/kg/day)
Number of subjects: 40
Study 2542384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg)
Number of subjects: 6
Study 2542384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg)
Number of subjects: 6
Study 2542384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 233825 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat fiber (36 g) added to diet for 3 weeks
Number of subjects: 6
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcurriculum confidence score (after completing the curriculum)
Number of subjects: 49
Study 31229695 — intervention group
Group type: EXPERIMENTAL
Intervention: Precurriculum confidence score (before completing the curriculum)
Number of subjects: 49